| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
11,608 |
11,318 |
$2.82M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
5,578 |
5,243 |
$1.55M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,559 |
1,528 |
$356K |
| 80053 |
Comprehensive metabolic panel |
4,794 |
4,341 |
$38K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
25 |
25 |
$34K |
| 71045 |
Radiologic examination, chest; single view |
2,973 |
2,775 |
$34K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
177 |
169 |
$25K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
198 |
186 |
$24K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,476 |
2,405 |
$21K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,155 |
1,896 |
$18K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,518 |
1,348 |
$14K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,151 |
2,017 |
$11K |
| 85027 |
|
6,771 |
6,074 |
$10K |
| 70450 |
Computed tomography, head or brain; without contrast material |
208 |
184 |
$9K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
54 |
52 |
$5K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
404 |
401 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
440 |
433 |
$4K |
| 87070 |
|
327 |
320 |
$3K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
476 |
427 |
$2K |
| 83690 |
|
891 |
837 |
$2K |
| 81000 |
|
979 |
907 |
$1K |
| 84484 |
|
984 |
666 |
$1K |
| 76820 |
|
12 |
12 |
$1K |
| 87420 |
|
99 |
98 |
$1K |
| 83880 |
|
119 |
105 |
$580.56 |
| 83605 |
|
118 |
85 |
$485.61 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
13 |
13 |
$390.86 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
859 |
779 |
$377.88 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
277 |
258 |
$375.90 |
| 87040 |
|
107 |
56 |
$375.56 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
445 |
400 |
$369.55 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
15 |
12 |
$281.11 |
| 85610 |
|
93 |
84 |
$217.93 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
57 |
57 |
$207.38 |
| 81003 |
|
215 |
204 |
$168.28 |
| 81001 |
|
159 |
152 |
$143.42 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
74 |
64 |
$84.56 |
| 83735 |
|
120 |
99 |
$73.41 |
| J7050 |
Infusion, normal saline solution, 250 cc |
258 |
219 |
$53.87 |
| 80061 |
Lipid panel |
13 |
12 |
$34.66 |
| 81025 |
|
32 |
30 |
$29.84 |
| 84443 |
Thyroid stimulating hormone (TSH) |
29 |
28 |
$21.73 |
| 87077 |
|
14 |
12 |
$19.97 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
27 |
26 |
$19.65 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
140 |
140 |
$17.72 |
| 82550 |
|
14 |
12 |
$16.08 |
| 82248 |
|
87 |
81 |
$15.21 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
27 |
24 |
$10.44 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
14 |
14 |
$10.35 |
| 85730 |
|
35 |
33 |
$7.08 |
| A9270 |
Non-covered item or service |
1,119 |
616 |
$6.37 |
| 84100 |
|
15 |
12 |
$6.13 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
110 |
106 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
13 |
12 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
30 |
30 |
$0.00 |